CongressBuys

Sen. James M. Inhofe sold CRISPR Therapeutics AG (CRSP)

Sen. James M. Inhofe (R-OK) · $50K–$100K · traded Dec 22, 2020

Transaction
Sold (partial)
Amount
$50K–$100K
Owner
The member
Traded
Dec 22, 2020
Disclosed
Dec 23, 2020
Days to disclose
1
Asset type
Stock
As filed
CRISPR Therapeutics AG
Industry
Biotechnology · Healthcare

Other trades in this filing

Recent Congress trades in CRSP

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.